Ring A, Kilburn LS, Pearson A, Moretti L, et al. Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clin Cancer Res 2023 Sep 29. doi: 10.1158/1078-0432.CCR-23-1696.
PMID: 37773077